120 related articles for article (PubMed ID: 11751511)
21. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
[TBL] [Abstract][Full Text] [Related]
22. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
23. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma.
Takei H; Iino Y; Horiguchi J; Kanoh T; Takao Y; Oyama T; Morishita Y
Anticancer Res; 1995; 15(3):1101-5. PubMed ID: 7544088
[TBL] [Abstract][Full Text] [Related]
25. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
27. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
Hulvat M; Rajan P; Rajan E; Sarker S; Schermer C; Aranha G; Yao K
Surgery; 2008 Oct; 144(4):518-24; discussion 524. PubMed ID: 18847634
[TBL] [Abstract][Full Text] [Related]
29. [Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
Merkle E; Bähr J; Henke A; Bühner M; Martus P
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):662-9. PubMed ID: 7531659
[TBL] [Abstract][Full Text] [Related]
30. Influence of tumor biological factors on tumor cell dissemination in primary breast cancer.
Fehm T; Becker S; Pergola-Becker G; Krämer B; Gruber I; Sotlar K; Kurek R; Wallwiener D; Solomayer E
Anticancer Res; 2004; 24(6):4211-6. PubMed ID: 15736474
[TBL] [Abstract][Full Text] [Related]
31. The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer.
Banys M; Krawczyk N; Becker S; Jakubowska J; Staebler A; Wallwiener D; Fehm T; Rothmund R
Breast Cancer Res Treat; 2012 Feb; 132(1):121-9. PubMed ID: 21562707
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
34. Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.
Vincent-Salomon A; Caly M; De Rycke Y; Fréneaux P; Klijanienko J; Laé M; Viard F; Nos C; Bidard FC; Alran S; Salmon R; Kirova Y; Pierga JY; Sigal-Zafrani B; Sastre-Garau X
Eur J Cancer; 2009 Jul; 45(11):1979-86. PubMed ID: 19375305
[TBL] [Abstract][Full Text] [Related]
35. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast.
Banys M; Gruber I; Krawczyk N; Becker S; Kurth R; Wallwiener D; Jakubowska J; Hoffmann J; Rothmund R; Staebler A; Fehm T
Breast Cancer Res Treat; 2012 Feb; 131(3):801-8. PubMed ID: 21455667
[TBL] [Abstract][Full Text] [Related]
36. Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
Becker S; Becker-Pergola G; Fehm T; Wallwiener D; Solomayer EF
Anticancer Res; 2005; 25(3B):2171-5. PubMed ID: 16158960
[TBL] [Abstract][Full Text] [Related]
37. Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells.
Kraemer B; Rothmund R; Banys M; Krawczyk N; Solomayer EF; Mack C; Wallwiener D; Fehm T
Anticancer Res; 2011 Dec; 31(12):4423-8. PubMed ID: 22199310
[TBL] [Abstract][Full Text] [Related]
38. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
39. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting.
Wang GY; Li Y; Yu YM; Yu B; Zhang ZY; Liu Y; Wang SJ
J Gastroenterol Hepatol; 2009 Feb; 24(2):299-306. PubMed ID: 19032456
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
